C4 Therapeutics Inc - CCCC - stock price prediction, stock price target, analyst ratings from 8 analysts

C4 Therapeutics Inc has a share price target of US$ 12, revenue growth forecast of -14.6%, and profit growth estimate of -14.9% for FY25, based on top 8 analyst calls.